Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)
Clinical trial NCT07289997 · RECRUITING
Trial details
- NCT number
- NCT07289997
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-28
- Primary completion
- 2027-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.